SelenBio On NetCapital - Plato AiStream V2.1

Publisert av Platon

Følgere: 0

Analytics

Hevet til dato: $147,972

Samlede forpliktelser $

Totalt: $' + total_amount_formatted + '

'; return(sveve); }, endre størrelse: sant, glatt: usant, vertikalGrid: sant }); jQuery('#analytics-tabs').on('change.zf.tabs', function(e) { if(jQuery('#deal_basics:visible').length){ totalChart.redraw(); jQuery(window) .trigger('endre størrelse'); } }); });

Plattform

Nettokapital

Startdato

10/03/2019

Lukk dato

04/28/2020

Min. Mål

$10,000

Maks. Mål

$1,070,000

Min. Investering

Sikkerhetstype

Egenkapital – Felles

Finansieringstype

RegCF

Serien

Seed

Pre-Money Verdivurdering

$19,621,196

Rullende forpliktelser $

Tidligere periode: $' + weekly_amount_formatted + '

'; return(sveve); }, endre størrelse: sant, glatt: usant, vertikalGrid: sant }); jQuery('#analytics-tabs').on('change.zf.tabs', function(e) { if(jQuery('#investment_momentum:visible').length){ weeklyChart.redraw(); jQuery(window) .trigger('endre størrelse'); } }); });

status

finansiert

Rapporteringsdato

05/03/2020

Dager igjen

finansiert

% av Min. Mål

1,480%

% av maks. Mål

14%

Sannsynlighet for Max

finansiert

Gj.sn. Daglig høyning

$711

Momentum

finansiert

Logg inn or Opprett en gratis konto i dag for å få tilgang til KingsCrowd analytics.

Sted

Industri

Helse og legemidler

Teknisk sektor

Biotech

Distribusjonsmodell

B2B

Margin

Høy

Kapitalintensitet

Høy

Type selskap

Høy vekst

SelenBio, a biotechnology company with a post-money valuation of $20.7 million, is raising funds on NetCapital. The company develops an antibacterial technology that prevents the formation of biofilm in dental, medical, industrial, and consumer applications. SelenBio uses a unique selenium-based compound, SELDOX, to keep the applications infection-free. The company was founded by Kenny Gallagher and Karl Doenges. The proceeds of the current crowdfunding round, with a minimum target of $10,000 and a maximum target of $1,070,000, will be used for research & development, operations, completion of current projects, sales & marketing, and compensation for managers. SelenBio is working on multiple projects with excellent traction and has already received the FDA approval for SELDOX.